
Introduction Laparoscopic cholecystectomy requires carbon dioxide pneumoperitoneum and changes in patient positioning, both of which can pathologically increase intracranial pressure (ICP). Measurement of the optic nerve sheath diameter (ONSD) by ultrasonography is a well-established, non-invasive method to monitor ICP. This study investigated how dexmedetomidine, administered at different doses, affects the extent of ONSD increase and stabilizes hemodynamic parameters during the surgery. Methods In this interventional prospective single-centred study, 75 ASA I/II patients were divided consecutively into three groups (n=25 each): Group NS received normal saline, Group D-0.3 received dexmedetomidine at 0.3 µg/kg/hr, and Group D-0.6 received dexmedetomidine at 0.6 µg/kg/hr. The primary endpoint was the observed ONSD values, assessed via ultrasonography at baseline (T0), 10 and 30 minutes after pneumoperitoneum initiation (T1 and T2), and 10 minutes after exsufflation (T3). Secondary outcomes assessed perioperative hemodynamic stability and sedation levels. Results Baseline demographics were similar across groups (P > 0.05). Group D-0.6 demonstrated significantly smaller ONSD values (4.67 ± 0.34, 4.59 ± 0.38 and 4.80 ± 0.30) at T1, T2, and T3 compared to Groups D-0.3 (5.74 ± 0.30, 6.12 ± 0.32 and 5.16 ± 0.33) and NS (5.66 ± 0.50, 6.20 ± 0.51 and 5.05 ± 0.42) (P < 0.005), with the greatest reduction observed at T2. Dexmedetomidine produced a dose-dependent decrease in heart rate and systolic blood pressure during periods of maximal surgical stress (P < 0.05), while maintaining stable mean arterial pressure and diastolic blood pressure. No episodes of bradycardia, hypotension and excessive sedation were recorded in any of 75 patients. Conclusion Dexmedetomidine effectively attenuated the laproscopy-induced increase in ONSD, a non-invasive surrogate of ICP, in a dose dependent manner, with an infusion rate of 0.6 µg/kg/hr showing a greater effect than 0.3 µg/kg/hr and preserved perioperative hemodynamic stability.
Background: Indirect calorimetry (IC) is recognized as the gold standard for measuring energy expenditure (EE) in clinical settings. Accurate assessment of EE is critical for optimizing nutritional therapy, particularly in critically ill patients, cancer patients, patients following major surgical procedures, and those requiring specialized metabolic care. Traditional methods of estimating EE, such as predictive equations, often result in inaccurate estimations due to variations in metabolic demands, disease states, and patient-specific factors. Indirect calorimetry provides a more individualized approach by directly measuring oxygen consumption (VO2) and carbon dioxide production (VCO2), enabling tailored nutritional support. This review aims to summarize the principles, methodologies, applications, advantages, and limitations of indirect calorimetry while comparing it to predictive equations and other methods of energy expenditure estimation. This study is a comprehensive review of the currently available literature on indirect calorimetry and its application in clinical nutrition. A structured literature search was conducted using electronic databases, including PubMed, Scopus and Google Scholar. The search strategy included searching by terms such as: "nutrition therapy", "indirect calorimetry, " "energy expenditure measurement, " "clinical nutrition, " "metabolic assessment, " and "critical care nutrition" in various combinations with the AND or OR operator connecting them. Indirect calorimetry provides a precise measurement of EE by assessing oxygen consumption (VO2) and carbon dioxide production (VCO2), applying the Weir equation for calculations. However, practical barriers such as cost, equipment availability, and the requirement for specialized training limit its widespread use. Conclusion: Indirect calorimetry remains the most accurate method for determining energy requirements in critically ill and surgical patients.
Introduction Eclampsia is a severe pregnancy-related hypertensive disorder, characterized by the onset of seizures in women with pre-existing preeclampsia, typically occurring after 20 weeks of gestation. It remains one of the leading causes of maternal morbidity and mortality worldwide, particularly in low-resource settings. Eclampsia and its precursor, severe preeclampsia, continue to present significant challenges in maternal health care, accounting for a substantial proportion of obstetric complications and maternal deaths, especially in sub-Saharan Africa, where access to specialized care is often limited. Background: Eclampsia, a severe complication of preeclampsia, remains a major cause of maternal morbidity and mortality, particularly in low-resource settings. Understanding the phenotypic profiles of affected women in intensive care units (ICUs) can improve risk stratification and guide targeted management. This study aimed to describe the clinical, biological, and evolutionary characteristics of women with eclampsia admitted to ICUs in Kinshasa. Methods: We conducted a multicenter cross-sectional study across six tertiary and secondary ICUs in Kinshasa from January 2019 to December 2022. All women admitted with eclampsia were included. Data were retrospectively collected from medical records and ICU registers, covering sociodemographic characteristics, clinical presentation, organ dysfunctions, therapeutic interventions, and maternal outcomes. Descriptive statistics summarized patient characteristics, and bivariate analyses identified factors associated with ICU mortality. Results: A total of 212 women were included. The median age was 29 years, and 68.4% were referred from other healthcare facilities. Primiparity was common (41.5%). Neurological complications were frequent, with 42.9% experiencing seizures and 17.5% presenting with a Glasgow Coma Scale ≤ 8. Renal dysfunction (21.7%), HELLP syndrome (12.7%), and pulmonary edema (16.5%) were also observed. Magnesium sulfate and antihypertensive therapy were administered to the majority of patients. Overall maternal mortality was 14.2%, predominantly among women with neurological, renal, or multi-organ involvement. Phenotypic classification revealed four main profiles: neurological, renal/HELLP, cardiovascular/respiratory, and multi-organ involvement, with the last exhibiting the highest risk of death. Conclusion: Eclampsia in Kinshasa primarily presents with neurological, renal, and cardiovascular complications, which strongly influence ICU mortality. Phenotypic classification offers a practical framework for early identification of high-risk patients, optimizing ICU management, and informing health strategies in resource-limited settings.
Introduction: In upper abdominal surgery, postoperative pain relief is the most challenging for anesthesiologist. Among multiple strategies, epidural analgesia using local anesthetics, opioids, or their combination, is popular technique for effective postoperative pain management. The aim of our study was comparison of effects of different doses of epidural tramadol for postoperative analgesia in adult patients scheduled for surgery of upper abdomen. Methods: This Prospective controlled interventional study included 60 adult patients posted for upper abdominal operations undergoing general anesthesia. The epidural analgesia was provided by administering 10 ml of epidural bupivacaine 0.25% via epidural catheter at the start of surgery and randomized into two different groups: Group A was administered 1 mg/kg tramadol diluted in 8 ml of normal saline and Group B was administered 2 mg/kg tramadol diluted in 8 ml of normal saline before extubation. Duration of analgesia, Pain score (numerical rating score-NRS), hemodynamic parameters and adverse event were monitored and time for need of first of rescue analgesic was recorded in both the groups. The student's t-test was used for analysis of continuous data. P value ≤0.05 was considered statistically significant. Result: Group B patients had significantly longer duration of postoperative analgesia (12.07 ± 1.48 hours) as compared to Group A (8.13 ± 0.82 hours) with P < 0.001. NRS pain score was significantly lower in Group B than in Group A. Hemodynamic parameter were comparable without any side effects in both the groups. Conclusion: Epidural tramadol 2 mg/kg resulted in superior and prolonged postoperative pain relief than epidural tramadol 1 mg/kg without compromising patient safety.